Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Jing, Hongbiao ^a   Zhang, Guoming ^a   Meng, Lingsheng ^b   Meng, Qingda ^b   Mo, Haiying ^c   Tai, Yanhong ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b Sixth People's Hospital of Jinan   (China)

^c Zaozhuang Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEASOME; PSMD10 PROTEIN, HUMAN;

ADULT; CARCINOGENESIS; FEMALE; GENE EXPRESSION; GENETICS; HEPG2 CELL LINE; HUMAN; KAPLAN MEIER METHOD; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY;

ADULT; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION; HEP G2 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS;

EID: 84904988455     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep05503     Document Type: Article

References (28)

1. Jemal, A. et al. Global cancer statistics. CA Cancer J Clin 61, 69-90 (2011).
2. Ozturk, M. Genetic aspects of hepatocellular carcinogenesis. Semin Liver Dis 19, 235-242 (1999). (Pubitemid 29488766)
3. Iakova, P., Timchenko, L. T. & Timchenko, N. A. Intracellular signaling and hepatocellular carcinoma. Seminars in Cancer Biology 21, 28-34 (2011).
4. International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 22, 983-993 (1995).
5. Higashitsuji, H. et al. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. NatMed 6, 96-99 (2000). (Pubitemid 30048534)
6. Krzywda, S. et al. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem 279, 1541-1545 (2004). (Pubitemid 38082684)
7. Yuan, C. et al. Solution structure of the human oncogenic protein gankyrin containing seven ankyrin repeats and analysis of its structure-function relationship. Biochemistry 43, 12152-12161 (2004). (Pubitemid 39280559)
8. Li, J. & Tsai, M. D. Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb. Biochemistry 41, 3977-3983 (2002). (Pubitemid 34251036)
9. Iwai, A. et al. Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. J Gastroenterol 38, 751-758 (2003). (Pubitemid 37161339)
10. Higashitsuji, H. et al. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8, 75-87 (2005). (Pubitemid 40991816)
11. Dawson, S., Higashitsuji, H.,Wilkinson, A. J., Fujita, J. &Mayer, R. J. Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol 16, 229-233 (2006). (Pubitemid 43728872)
12. Higashitsuji, H., Liu, Y., Mayer, R. J. & Fujita, J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell cycle 4, 1335-1337 (2005). (Pubitemid 41437115)
13. Tan, L. et al. Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma. Liver International 25, 667-676 (2005). (Pubitemid 40861916)
14. Park, T. J. et al. Sequential changes in hepatocarcinogenesis induced by diethylnitrosamine plus thioacetamide in Fischer 344 rats: induction of gankyrin expression in liver fibrosis, pRB degradation in cirrhosis, and methylation of p16(INK4A) exon 1 in hepatocellular carcinoma. Mol Carcinog 30, 138-150 (2001). (Pubitemid 32274077)
15. Fu, X. Y. et al. Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance. World J Gastroenterol l8, 638-643 (2002).
16. Lim, I. K. Spectrumofmolecular changes during hepatocarcinogenesis induced by DEN and other chemicals in Fischer 344 male rats. Mech Ageing Dev 123, 1665-1680 (2002). (Pubitemid 35449230)
17. Umemura, A. et al. Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology 47, 493-502 (2008). (Pubitemid 351280717)
18. Fu, J. et al. p28GANK overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3-kinase/AKT/hypoxiainducible factor-1a pathways. Hepatology 53, 181-192 (2011).
19. Sun, W. et al. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells. Hepatology 54, 1259-1272 (2011).
20. Qian, Y. W. et al. p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology 142, 1547-1558 (2012).
21. Grazioli, L., Olivetti, L.&Orlando, E. Cirrhosis and pre-neoplastic lesions. Abdom Imaging 37, 188-214 (2012).
22. Malumbres, M. & Barbacid, M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 1, 222-231 (2001). (Pubitemid 33741897)
23. Velazquez, R. F. et al. Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology 37, 520-527 (2003). (Pubitemid 36258772)
24. Anzola, M. et al. High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma. J Viral Hepat 11, 502-510 (2004). (Pubitemid 39486613)
25. Theise, N. D. et al. Hepatocellular carcinoma. In: Bosman, F. T., Carneiro, F., Hruban, R. H. & Theise, N. D. eds.WHOclassification of tumours of the digestive system. 4th ed. IARC: Lyon, 205-216 (2010).
26. Li, W. et al. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle 11, 1-11 (2012).
27. Ortiz, C. M. et al. Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer 122, 325-332 (2008). (Pubitemid 350234718)
28. Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688 (2007). (Pubitemid 47552092)